Depressive Disorders - MGH Center for Women's Mental Health

Omega-3 Fatty Acids and Perinatal Depression: Maybe or Maybe Not

The omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA), have a broad range of health benefits and may be beneficial for the treatment of mood disorders. Because during pregnancy omega-3 fatty acids are diverted to the developing fetus, some women may develop a deficiency of omega-3 fatty acids during pregnancy. Previous studies have shown that pregnant women with lower levels of DHA may be more vulnerable to depressive symptoms. Several small studies have attempted to use omega-3 fatty acids to treat perinatal depression but have yielded inconsistent findings.

By MGH Center for Women's Mental Health|2015-08-07T14:43:16-04:00May 6th, 2013|Depressive Disorders, Psychiatric Disorders During Pregnancy|Comments Off

Research from the CWMH: Duloxetine for Menopausal Symptoms

A substantial proportion of women transitioning into menopause experience a new onset or recurrence of depressive symptoms. A new study from the Center for Women’s Mental Health indicates that duloxetine (Cymbalta) is effective for the treatment of depression and may also have a beneficial effect on vasomotor symptoms (hot flashes and night sweats).

By MGH Center for Women's Mental Health|2015-08-06T11:08:15-04:00April 29th, 2013|Depressive Disorders, Medication, Menopausal Symptoms, Research at CWMH, Treatment, Vasomotor Symptoms|Comments Off

Hormonal Treatments for Breast Cancer: Do They Cause Depression?

Aromatase inhibitors (AIs) are the preferred hormonal therapy for postmenopausal women with estrogen sensitive breast cancer. While the selective estrogen receptor modulators (SERMs), such as tamoxifen and raloxifene, are used in premenopausal women with estrogen sensitive breast cancer, the aromatase inhibitors (e.g., anastrozole, letrozole, and exemestane) have been shown to be more effective and safer than the SERMs in postmenopausal women.

By MGH Center for Women's Mental Health|2015-08-06T11:57:42-04:00April 9th, 2013|Breast Cancer, Depressive Disorders, Hormone Therapy, Menopausal Symptoms|Comments Off

Father’s Psychological Health and Its Impact on Child Development

While much attention has focused on the impact of maternal psychiatric illness on the well-being of the child, less is known about the impact of psychiatric illness in the father. A large population-based study from Norway examines the association between symptoms of psychological distress in expectant fathers and socioemotional and behavioral outcomes in their children at 36 months of age.

By MGH Center for Women's Mental Health|2017-03-28T09:56:33-04:00January 22nd, 2013|Child Outcomes, Depressive Disorders, Outcomes, Postpartum Psychiatric Disorders|Comments Off

Hyperemesis Gravidarum and Depression: Which Comes First?

Most women have some nausea or vomiting, or "morning sickness", during the first trimester of pregnancy. Some women, however, have a more severe and persistent pattern of nausea and vomiting called hyperemesis gravidarum (HG). A new study demonstrates, not so surprisingly, that depression is more common in women suffering from HG.

By MGH Center for Women's Mental Health|2015-08-06T13:44:18-04:00January 15th, 2013|Depressive Disorders, Prevalence & Risk Factors, Psychiatric Disorders During Pregnancy|Comments Off

Brief Scales for Identifying Postpartum Depression and Anxiety

While most agree that there is a need for improved detection of anxiety and mood disorders in pregnant and postpartum women, there remain questions regarding the best instruments to use for screening. The Edinburgh Postnatal Depression Scale (a questionnaire consisting of 10 items) has long been used to screen women for postpartum depression (PPD); however, it is unclear how well these questions could be incorporated into larger surveillance programs, such as the CDC-sponsored Pregnancy Risk Assessment Monitoring System (PRAMS) which was designed to assess health behaviors and to screen for health problems, including depression and anxiety, in pregnant and postpartum women.

By MGH Center for Women's Mental Health|2015-08-06T13:54:12-04:00December 13th, 2012|Anxiety Disorders, Depressive Disorders, Diagnosis & Screening, Postpartum Psychiatric Disorders|Comments Off

Is There a Link Between Vitamin D Deficiency and Antenatal Depression?

Several studies have shown that vitamin D deficiency is associated with depression. A recent study has assessed the relationship between vitamin D levels and risk for antenatal depression in a cohort of African-American women. Vitamin D deficiency is more common among African-American women than in Caucasians. The active form of vitamin D is produced as a byproduct of natural sun exposure. Because women with darker skin have more melanin, which blocks the sun’s rays and affects the skin’s ability to produce the active form of vitamin D, they typically have lower vitamin D levels.

By MGH Center for Women's Mental Health|2015-08-11T09:37:16-04:00November 3rd, 2012|Depressive Disorders, Prevalence & Risk Factors, Psychiatric Disorders During Pregnancy|Comments Off

Depression in Fathers: Toward a Better Understanding of Its Impact on the Child

While much research has demonstrated that maternal depression may negatively affect the child, leading to increased risk of developmental delays, behavioral problems, and psychiatric illness. Less research, however, has detailed the impact of paternal depression; several recent studies have focused on better understanding the risk factors for paternal depression and how paternal depression affects children.

By MGH Center for Women's Mental Health|2015-08-11T09:45:19-04:00October 23rd, 2012|Child Outcomes, Depressive Disorders, Outcomes, Postpartum Psychiatric Disorders|Comments Off

Screening for Perinatal Depression: What Can We Learn From Australia?

In 2009, the Australian government launched the National Perinatal Depression Initiative (NPDI) in order “to improve the prevention and early detection of antenatal and postnatal depression and to provide better support and treatment for expectant and new mothers experiencing depression.” Its scope is very much like the MOTHERS Act, which became law in the United States in 2010. Both initiatives seek to increase public awareness of perinatal depression, to provide support and treatment for pregnant and postpartum women with depression, to fund research in this area, and to implement training of health care professionals.

By MGH Center for Women's Mental Health|2015-08-11T09:57:25-04:00October 17th, 2012|Depressive Disorders, Diagnosis & Screening, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off

CBT for Depression During Pregnancy Improves Mothers’ Attentiveness to Her Infant

During pregnancy, a woman develops increasing sensitivity and responsiveness to infants’ distress. If depression during pregnancy occurs, this process may be disrupted. Various studies are shown that women with depression are less responsive to an infant’s distress. The major concern is that this diminished responsiveness may persist as long as one year after the child is born, and when it persists, it may negatively affect the child. Decreased responsiveness of the mother to the infant’s cues may lead to emotional, cognitive and developmental problems in the child later on.

By MGH Center for Women's Mental Health|2015-08-12T11:25:09-04:00October 10th, 2012|Depressive Disorders, Psychiatric Disorders During Pregnancy, Psychotherapy, Treatment|Comments Off